Modification or dose or treatment duration has no impact on outcome of AML patients: preliminary results of the UK NCRI AML 14 trail

AK Burnett, Donald Milligan, AG Prentice, A Goldstone, A McMullin, Robert Hills, Keith Wheatley

Research output: Contribution to journal › Abstract

Cite this

@article{c4580d516f534470a8a06b6c59f024d0,

title = "Modification or dose or treatment duration has no impact on outcome of AML patients: preliminary results of the UK NCRI AML 14 trail",

author = "AK Burnett and Donald Milligan and AG Prentice and A Goldstone and A McMullin and Robert Hills and Keith Wheatley",

year = "2005",

month = jan,

day = "1",

language = "English",

volume = "106",

pages = "162a",

journal = "Blood",

issn = "1528-0020",

publisher = "American Society of Hematology",

number = "11",

}

TY - JOUR

T1 - Modification or dose or treatment duration has no impact on outcome of AML patients: preliminary results of the UK NCRI AML 14 trail

AU - Burnett, AK

AU - Milligan, Donald

AU - Prentice, AG

AU - Goldstone, A

AU - McMullin, A

AU - Hills, Robert

AU - Wheatley, Keith

PY - 2005/1/1

Y1 - 2005/1/1

M3 - Abstract

SN - 1528-0020

VL - 106

SP - 162a

JO - Blood

JF - Blood

IS - 11

ER -